136 related articles for article (PubMed ID: 35305235)
1. Expression of BDNF-Associated lncRNAs in Parkinson's disease.
Akbari M; Gholipour M; Hussen BM; Taheri M; Eslami S; Sayad A; Ghafouri-Fard S
Metab Brain Dis; 2022 Apr; 37(4):901-909. PubMed ID: 35305235
[TBL] [Abstract][Full Text] [Related]
2. Blood and tissue levels of lncRNAs in periodontitis.
Sayad A; Ghafouri-Fard S; Shams B; Arsang-Jang S; Gholami L; Taheri M
J Cell Physiol; 2020 Dec; 235(12):9568-9576. PubMed ID: 32372456
[TBL] [Abstract][Full Text] [Related]
3. Expression of BDNF-Associated lncRNAs in Treatment-Resistant Schizophrenia Patients.
Badrlou E; Ghafouri-Fard S; Omrani MD; Neishabouri SM; Arsang-Jang S; Taheri M; Pouresmaeili F
J Mol Neurosci; 2021 Nov; 71(11):2249-2259. PubMed ID: 33403596
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's Disease Is Associated With Dysregulation of Circulatory Levels of lncRNAs.
Honarmand Tamizkar K; Gorji P; Gholipour M; Hussen BM; Mazdeh M; Eslami S; Taheri M; Ghafouri-Fard S
Front Immunol; 2021; 12():763323. PubMed ID: 34868009
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of Circulatory Levels of lncRNAs in Parkinson's Disease.
Huang T; Zhao JY; Pan RR; Jiang T; Fu XX; Huang Q; Wang XX; Gong PY; Tian YY; Zhang YD
Mol Neurobiol; 2023 Jan; 60(1):317-328. PubMed ID: 36264433
[TBL] [Abstract][Full Text] [Related]
6. BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's Disease.
Fischer DL; Auinger P; Goudreau JL; Cole-Strauss A; Kieburtz K; Elm JJ; Hacker ML; Charles PD; Lipton JW; Pickut BA; Sortwell CE
Neurotherapeutics; 2020 Oct; 17(4):1785-1795. PubMed ID: 33215284
[TBL] [Abstract][Full Text] [Related]
7. Gene polymorphisms and motor levodopa-induced complications in Parkinson's disease.
Michałowska M; Chalimoniuk M; Jówko E; Przybylska I; Langfort J; Toczylowska B; Krygowska-Wajs A; Fiszer U
Brain Behav; 2020 Mar; 10(3):e01537. PubMed ID: 32022467
[TBL] [Abstract][Full Text] [Related]
8. Association of the Plasma Long Non-coding RNA
Quan Y; Wang J; Wang S; Zhao J
Front Neurol; 2020; 11():532891. PubMed ID: 33329296
[No Abstract] [Full Text] [Related]
9. Peripheral BDNF/TrkB protein expression is decreased in Parkinson's disease but not in Essential tremor.
Huang Y; Huang C; Yun W
J Clin Neurosci; 2019 May; 63():176-181. PubMed ID: 30723034
[TBL] [Abstract][Full Text] [Related]
10. Serum concentration and clinical significance of brain-derived neurotrophic factor in patients with Parkinson's disease or essential tremor.
Huang Y; Yun W; Zhang M; Luo W; Zhou X
J Int Med Res; 2018 Apr; 46(4):1477-1485. PubMed ID: 29350074
[TBL] [Abstract][Full Text] [Related]
11. LncRNA BDNF-AS promotes autophagy and apoptosis in MPTP-induced Parkinson's disease via ablating microRNA-125b-5p.
Fan Y; Zhao X; Lu K; Cheng G
Brain Res Bull; 2020 Apr; 157():119-127. PubMed ID: 32057951
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis on the role of brain-derived neurotrophic factor in Parkinson's disease patients.
Chen Z; Zhang H
Adv Clin Exp Med; 2023 Mar; 32(3):285-295. PubMed ID: 36398374
[TBL] [Abstract][Full Text] [Related]
13. Genome-Scale Expression Pattern of Long Non-Coding RNAs in Chinese Uyghur Patients with Parkinson's Disease.
Wang D; Gao H; Li Y; Jiang S; Yong Y; Yang X
Med Sci Monit; 2020 Oct; 26():e925888. PubMed ID: 33031356
[TBL] [Abstract][Full Text] [Related]
14. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases.
Wu P; Zuo X; Deng H; Liu X; Liu L; Ji A
Brain Res Bull; 2013 Aug; 97():69-80. PubMed ID: 23756188
[TBL] [Abstract][Full Text] [Related]
15. BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease.
Guerini FR; Beghi E; Riboldazzi G; Zangaglia R; Pianezzola C; Bono G; Casali C; Di Lorenzo C; Agliardi C; Nappi G; Clerici M; Martignoni E
Eur J Neurol; 2009 Nov; 16(11):1240-5. PubMed ID: 19538209
[TBL] [Abstract][Full Text] [Related]
16. Expression Analysis of BDNF Gene and BDNF-AS Long Noncoding RNA in Whole Blood Samples of Multiple Sclerosis Patients: Not Always a Negative Correlation between Them.
Gharzi V; Gangi M; Sayad A; Mazdeh M; Arsang-Jang S; Taheri M
Iran J Allergy Asthma Immunol; 2018 Dec; 17(6):548-556. PubMed ID: 30644699
[TBL] [Abstract][Full Text] [Related]
17. Expression Analysis of NF-κB-Related lncRNAs in Parkinson's Disease.
Ghafouri-Fard S; Gholipour M; Abak A; Mazdeh M; Taheri M; Sayad A
Front Immunol; 2021; 12():755246. PubMed ID: 34721431
[TBL] [Abstract][Full Text] [Related]
18. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in Parkinson's disease and age of onset.
Hong CJ; Liu HC; Liu TY; Lin CH; Cheng CY; Tsai SJ
Neurosci Lett; 2003 Dec; 353(1):75-7. PubMed ID: 14642442
[TBL] [Abstract][Full Text] [Related]
19. Brain-derived neurotrophic factor concentrations in the cerebrospinal fluid of patients with Parkinson's disease.
Salehi Z; Mashayekhi F
J Clin Neurosci; 2009 Jan; 16(1):90-3. PubMed ID: 19017558
[TBL] [Abstract][Full Text] [Related]
20. Role of Apolipoprotein E, Cathepsin D, and Brain-Derived Neurotrophic Factor in Parkinson's Disease: A Study from Eastern India.
Pal P; Sadhukhan T; Chakraborty S; Sadhukhan S; Biswas A; Das SK; Ray K; Ray J
Neuromolecular Med; 2019 Sep; 21(3):287-294. PubMed ID: 31134487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
